Who makes tirofiban in PV?

tirofiban in PV is developed by The First Affiliated Hospital with Nanjing Medical University.

Last reviewed 2026-04-20 · How we verify

tirofiban in PV

The First Affiliated Hospital with Nanjing Medical University · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	tirofiban in PV
Also known as	GPⅡb/Ⅲa receptor antagonist
Sponsor	The First Affiliated Hospital with Nanjing Medical University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

tirofiban in PV CI brief — competitive landscape report
tirofiban in PV updates RSS · CI watch RSS
The First Affiliated Hospital with Nanjing Medical University portfolio CI